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Abstract
Tandem mass spectrometry (MS/MS) is the key technology for glycopeptide identification
in high-throughput large-scale glycoproteomics. Estimation of false discovery rates (FDR) is
essential for evaluating the quality of the MS/MS-based identification software tools. Although
numerous glycopeptide identification tools have been recently proposed, there have been few
widely accepted approaches for glycopeptide FDR analysis due to the great structural diversity
of glycans. The target-decoy search strategy is currently the most common method for FDR
estimation of peptide-spectral matches. In this study, we constructed decoy glycan databases
by various methods and compared the FDR from the database search scores produced by each
decoy glycan database. Furthermore, we employed a mixture model that facilitates distinguishing between correct and incorrect identifications among the database search score distribution
for a better comparison of different decoy glycan database constructions.

Keywords: Tandem mass spectrometry, false discovery rate, target-decoy search strategy
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Summary for Lay Audience
Tandem mass spectrometry (MS/MS) is an essential tool to identify chemical substances.
Since various glycopeptide identification software have been developed for the past decades,
a large quantity of MS/MS data can be identified in a single run of this software. In largescale glycoproteomics, false discovery rate (FDR) estimation plays a vital role to evaluate the
identification results produced by the software because the results may contain incorrect assignments, and manually checking them is not feasible for large datasets. Although extensive
research has been carried out on FDR estimation in proteomics, there have been few widely
accepted approaches to FDR analysis for glycan because of their structural diversity. Targetdecoy search strategy is the standard method to estimate FDR in proteomics, where the sequencing software searches the real target database and incorrect decoy database. In this study,
we generated different kinds of decoy glycan databases and compared the effectiveness of the
databases for reasonable FDR estimation of glycopeptide identification. To compare the decoy glycan database, we used a mixture model for the differentiation of correct and incorrect
glycopeptide assignments.
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Chapter 1
Introduction
1.1 Glycoproteomics
Protein glycosylation is one of the most common and important post-translational modification
(PTM). Glycosylation is the covalent attachment of glycans to proteins and occurs not only in
animals and plants but also in all other domains of life, such as bacteria and archaea. Protein
glycosylation is mediated by glycosyltransferases, the enzymes that catalyze the glycosidic
linkages. Interactions between glycosyltransferases, carbohydrate transporters, and glycosidases regulate glycan structures and their functions. Previous research reported that more than
50% of all peptides are modified by glycosylation [1]. It has been estimated that at least 50%
and as high as 70% of human proteins are glycosylated [2] and the modification plays a critical
role in various biological processes such as protein folding, cell signaling, cellular development, host-microorganism interactions, and immunity. Previous research has found possible
relationships between glycosylation and several diseases including Alzheimer’s disease and
cancers [3] [4].
Glycoproteomics is an actively developing area of research that identifies and characterizes
glycosylation at a proteome scale. Glycosylation has not yet been fully understood because,
unlike other simple PTMs such as phosphorylation and acetylation, the great structural diversity of glycans and the heterogeneity of glycosylation sites make the glycoproteomics analysis
significantly more challenging. A single protein can have hundreds of possible glycan attachments and a specific site of N-linked and O-linked glycosylation can be carried by numerous
1
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different glycans [5].

1.1.1 N-linked/O-linked glycans

Various types of glycosylations have been observed that have different target residues for modification and glycosylation sites within proteins. Among them, there are two main types of
glycans: N-linked glycans and O-linked glycans. N-linked glycans are attached to asparagine
(Asn) side chains in a part of consensus amino acid sequence motif of Asn-X-serine (Ser)/
threonine (Thr), where X can be any amino acid apart from proline (Pro). N-linked glycans commonly have the core glycan structure GlcNAc2 Man3 , which is composed of two Nacetylglucosamine (GlcNAc) residues linked to three mannose (Man) residues. Glycans are
classified into three groups: high-mannose, complex, and hybrid. High-mannose N-linked glycans have the core structure to which many mannose residues are attached. Complex N-linked
glycans consist of the core structure with any type of monosaccharides. Hybrid N-linked glycans have mannose residues on one side of the core structure and complex residues on the other
side of the core structure.
O-linked glycans are typically attached to serine (Ser) or threonine (Thr) residues. The
most commonly presented monosaccharide is N-acetylgalactosamine (GalNAc) in O-linked
glycans, but there is no known consensus amino acid sequence for O-linked glycans as opposed
to N-linked glycans. It has been estimated that there are up to 3000 N-linked and O-linked
glycans in humans [6]. Aside from GlcNAc, Man and GalNAc, there are several common
monosaccharides in N-linked and O-linked glycans such as galactose (Gal), Glucose (Glc),
Fucose (Fuc), Xylose (Xyl), N-acetylneuraminic acid (Neu5Ac), and N-glycolylneuraminic
acid (Neu5Gc).
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Figure 1.1: Three types of N-glycan [2]

1.1.2 Sequence format for glycans
There are a number of sequence formats to linearly or graphically represent glycan structures. Complex Carbohydrate Structure Database (CCSD, also called CarbBank) [7] uses
two-dimensional graphical representations to represent glycan sequences. KCF [8] employs
the connection table approach as used by the Kyoto Encyclopedia of Genes and Genomes
(KEGG) specifying NODE section for monosaccharides and EDGE section for glycosidic
linkages. Glycan data exchange format (Glyde) [9] and CabosML [10] are XML (Extensible Markup Language)-based formats to represent glycomics data regardless of different data
acquisition and processing systems. GlycoMinds LinearCode [11], LINUCS applied in GLYCOSCIENCES.de. [12], and Bacterial carbohydrate structure database (BCSDB) [13] represent carbohydrate sequences uniquely with a condensed description of the monosaccharides,
connections, and modifications in a linear fashion.
These glycan sequence formats have different ability to encode complex structural features
in glycans and none of the current glycan encoding systems can perfectly handle the complex
carbohydrate structural data (Table 1.1, where + represents special structual fearures can be
encoded, - represents the fearures cannot be encoded, and O means the fearures can be partially
encoded). To overcome those limitations of the existing carbohydrate sequence formats, Herget
et al. proposed GlycoCT format [14].

4
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Table 1.1: Glycan format comparison [14]

GlycoCT
GlycoCT is a connection table-based glycan representation format. GlycoCT employs a graph
notation with the residue list containing all the monosaccharides in a glycan and the connectivity list describes all the unique linkages between each monosaccharide (Figure 1.2).

Figure 1.2: GlycoCT general concept [14]

In the residue list, GlycoCT uses five attributes to represent glycan features: anomeric
carbon configuration, three-letter stem type code with configuration, the number of carbons in
the chain, ring forming positions, and modifier information (Figure 1.3). GlycoCT does not
use trivial names like fucose for consistency, but, if needed, these names can be created using
other software tools such as GlycanBuilder [15].

1.1. Glycoproteomics
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Figure 1.3: GlycoCT residue section [14]

The connectivity list is made up of all the linkages of the monosaccharides in the residue
list with the information of residue numbers corresponding to those in the residue list and
modification patterns of the linkage by chemical bond formation.

Figure 1.4: GlycoCT linkage section [14]

6
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1.2 Mass spectrometry
1.2.1 Mass spectrometry
Mass spectrometry (MS) is a widely used method for analyzing complex protein samples. Proteomics based on mass spectrometry is an essential technology for interpreting gene-encoded
information. A mass spectrometer basically consists of the ion source, the mass analyzer, and
the detector. A mass spectrometer first produces ions from the sample (liquid or gas) in the ion
source. Then, it separates ions according to their mass-to-charge ratio, m/z (m means the relative mass of the ions in Daltons (Da), and z means the number of charges, which is counted in
accordance with the charge of one electron in absolute value), and fragments the selected ions
in the mass analyzer. After that, the mass spectrometer detects the ions, measures the number
of ions at each m/z value, which is called abundance, and converts them into electrical signals
in the detector. Finally, it processes and records the signals, and transmits them to a computer.
The output of a mass spectrometer is a spectrum represented as a set of m/z and intensity pairs.
The mass spectrum is mostly shown as a bar graph. The x-axis indicates m/z and the y-axis
indicates the intensity, or relative abundance, which is the figure proportional to the number of
ions detected in per cent of the most abundant one.

1.2.2 Tandem Mass Spectrometry
The mass analyzer is the fundamental part of the mass spectrometer. Tandem mass spectrometry (MS/MS) is a technique using several analyzers to increase the key parameters in proteomics: the sensitivity, resolution, accuracy of mass measurement, and the ability to generate
spectra with a lot of information from peptide fragments. In bottom-up proteomics, proteins
are first broken into short peptides by proteases (e.g., trypsin), because the whole protein mass
spectrometry is less sensitive than that of the peptide level. Then, the first spectrometer (MS1)
selects a precursor ion, which represents a peptide, and fragments it through collision. The
second spectrometer (MS2) records and analyzes m/z of each fragmented ion, which is called
a product ion. Analyzing the product ions provides information about the peptide sequences

1.2. Mass spectrometry
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(Figure 1.5).

Figure 1.5: Proteomics workflow [16]

1.2.3 Mass spectrometry-based glycoproteomics
Mass spectrometry (MS)-based proteomics has been a standard method for the identification
and quantification of glycoproteins thanks to the developments in MS instrumentation, fragmentation strategies, and high-throughput workflows over the past decades. Glycopeptide characterization is often difficult because glycopeptides are low in abundance and commonly used
fragmentation methods preferably dissociate glycan with fewer peptide fragments. For these
challenges, the traditional approach to identifying glycopeptides is a separation of glycans from
peptides by deglycosylation. For N-linked glycopeptides, the enzyme PNGase F is commonly
used to remove glycans from glycopeptides [17]. The separated peptides and glycans subsequently are analyzed to identify and characterize peptide sequences, glycosylation sites, and
glycan structures. This approach, however, has a drawback in that a glycosylation site and the
corresponding glycan structural information cannot be directly obtained. The alternative ap-

8
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proach to the deglycosylation strategy is the intact glycopeptide strategy. This strategy leaves
glycan attachments to peptides intact, and thus makes it possible to obtain the information for
peptide sequences, glycosylation sites, and glycan structure concurrently [18].

1.2.4 Dissociation methods
It is necessary for intact glycopeptide analysis to employ high sensitivity and high throughput
tools that can provide fragments from peptide backbones and attached glycans. Several MS
peptide fragmentation methods have been developed, which can be classified into two groups
by their energy deposition: vibrational methods and electronic methods. The vibrational methods include low-energy collision-induced dissociation (CID), higher-energy collisional dissociation (HCD), and infrared multiphoton dissociation (IRMPD), while the electronic methods
include electron capture dissociation (ECD), electron transfer dissociation (ETD) and ultraviolet photodissociation (UVPD).
Using these methods, peptides and glycans are dissociated into many smaller fragment
ions. Peptide fragment ions from the C-terminus are labeled as x1 , y1 , and z1 to xn , yn , and
zn , where n is the number of amino acids in the peptide. The other types of peptide fragment
ions from the N-terminus are called a1 , b1 , and c1 to an , bn , and cn (Figure 1.6). In the same
manner, glycan fragment ions from the reducing end are labeled as X1 , Y1 , and Z1 to Xn , Yn ,
and Zn , from the non-reducing end are A1 , B1 , and C1 to An , Bn , and Cn (Figure 1.7). Different
dissociation methods produce different types of fragment ions.
CID [19] is the most employed method to elucidate peptides and glycans. HCD [20] is
a higher energy version of CID specific to modern orbitrap mass spectrometers. CID and
HCD mostly cleave glycosidic linkages. The single-bond cleavages of precursor ions and
low dissociation energy by CID produce abundant B-ions and Y-ions for glycan fragments,
and a few b-ions and y-ions for peptide backbone fragments, which are useful information to
determine glycan composition, but uninformative for glycosylation sites and peptide sequences
(Figure 1.8). In addition to the ions fragmented by CID, HCD can generate several diagnostic
oxonium ions, which can be used to distinguish glycan structures. The common oxonium ions

1.2. Mass spectrometry
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are HexNAc internal fragment (m/z = 138.05), Hex (m/z = 163.06), HexNAc (m/z = 204.09),
Neu5Ac-H2 O (m/z = 274.09), Neu5Ac (m/z = 292.10), Hex+HexNAc (m/z = 366.14) [21]
(Table 1.2). HCD can produce b- and y- peptide fragment ions, but is likely to lose their glycan
modifications. CID and HCD can also produce A-ions and X-ions resulting from cross-ring
fragmentation, which can be informative for glycan structure identification, by modulating the
collision energy.
ECD [22] and ETD [23] generate mostly c- and z- peptide backbone fragments that keep
glycan moieties intact, which are used to identify peptide sequences and glycosylation sites.
Due to the drawbacks of ETD such as incomplete fragmentation of precursor ions, ETD is
often combined with CID/HCD for glycopeptide characterization.

Monosaccharide

Table 1.2: Monosaccharide mass

Galactose
Glucose
Mannose
N-Acetylgalactosamine
N-Acetylglucosamine
Fucose
Xylose
N-Acetylneuraminic acid
N-Glycolylneuraminic acid

Abbreviation

Formula

Gal
Glc
Man
GalNAc
GlcNAc
Fuc
Xyl
Neu5Ac
Neu5Gc

C6 H12 O6
C6 H12 O6
C6 H12 O6
C8 H15 NO6
C8 H15 NO6
C6 H12 O5
C5 H10 O5
C11 H19 NO9
C11 H19 NO10

Monoisotopic mass
162.0528
162.0528
162.0528
203.0794
203.0794
146.0579
132.0423
291.0954
307.0903

1.2.5 Hybrid fragmentation methods
The recent approaches that combine these multiple dissociation techniques are called hybrid
fragmentation methods. Hybrid fragmentation methods can complement the limitation of each
method and produce more ions and different ion types. In CID/HCD, different fragmentation
energy generates different fragmentation types. By stepped collision energy, or SCE, which
applies different collisional energy for the same ion groups, more diversified fragmentation
ions can be produced [27]. Low energy fragmentation generates B-ions, intermediate energy
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Electron transfer/higher-energy collisional dissociation (EThcD) [30], a combination of

the collisional dissociation method and the electron dissociation method, produces abundant
structural information on glycopeptides with both glycan fragment ions and peptide backbone
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Figure 1.7: Glycan fragmentation [25]

Figure 1.8: Glycopeptide fragmentation by diffrerent dissociation methods [26]

fragment ions in one single spectrum. Previous research shows EThcD outperforms ETD and
HCD for larger glycopeptides [31].

1.2.6 Peptide identification strategy
There are three common strategies for peptide identification: database searching, spectral library searching, and de novo sequencing. Database searching [32] is the most widely used
strategy for peptide identification and characterization in bottom-up proteomics. The strategy is to match experimental MS/MS data with a theoretically possible sequence in reference
proteome databases including UniProtKB [33] and NCBI RefSeq [34]. If proteases have a
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known digestion pattern and peptides have a known fragmentation pattern, a list of plausible
peptides and corresponding fragments is produced. By computationally comparing the experimental mass spectrum with the theoretical fragment masses (Table 1.3), peptides are scored
and ranked depending on the degree of matching between candidate peptides and the experimental data, and the best-scoring peptide is reported. The most common search engines for
database searching are SEQUEST [35] and MASCOT [36].
Database searching has drawbacks in that the strategy heavily depends on the quality and
availability of reference databases. When an organism of interest has not been sequenced, or
when there are no accurate reference databases because of splice variants, single amino acid
variations and PTMs, database searching does not work well. Database searching also has
some disadvantages such as false positive identifications caused by noisy spectra and scoring
imbalances between low-quality long peptides and high-quality short peptides. One of the alternative strategies to database searching is a direct spectrum-to-spectrum comparison between
experimental MS/MS spectra and reference.
MS/MS spectra in a spectral library is referred to as spectral library searching [37]. Although spectral library searching has lower processing times and potentially higher identification rates compared to database searching, it also relies on available accurate reference
databases for spectrum data. To compare theoretical and experimental data, a sufficient amount
of precisely annotated MS/MS spectra is needed in spectral libraries.
When there is no appropriate database and to overcome those disadvantages of the databasedependent approach, de novo sequencing [38] approach is the only way for peptide identification. De novo sequencing can reconstruct the original amino acid sequences from an MS/MS
spectrum and make it possible to identify previously unknown peptide sequences, peptide homologues, and modifications. Also, the results of de novo sequencing can be used to validate
the results of database searching, because both results are very similar [39]. There are various
widely used de novo sequencing software available such as PEAKS [40], Novor [41], and PepNovo [42].

1.3. False discovery rates and target-decoy approach
Table 1.3: Amino acid mass

Residue
Alanine
Arginine
Asparagine
Aspartic acid
Cysteine
Glutamine
Glutamic acid
Glycine
Histidine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine

3-letter
code

1-letter
code

Ala
Arg
Asn
Asp
Cys
Gln
Glu
Gly
His
Ile
Leu
Lys
Met
Phe
Pro
Ser
Thr
Trp
Tyr
Val

A
R
N
D
C
Q
E
G
H
I
L
K
M
F
P
S
T
W
Y
V

Formula
C3 N5 NO
C6 H12 N4 O
C4 H6 N2 O2
C4 H5 NO3
C3 H5 NOS
C5 H8 N2 O2
C5 H7 NO3
C2 H3 NO
C6 H7 N3 O
C6 H11 NO
C6 H11 NO
C6 H12 N2 O
C5 H9 OS
C9 H9 NO
C5 H7 NO
C3 H5 NO2
C4 H7 NO2
C11 H10 N2 O
C9 H9 NO2
C5 H9 NO
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Monoisotopic
mass
71.03712
156.10112
114.04293
115.02695
103.00919
128.05858
129.04260
57.02147
137.05891
113.08407
113.08407
128.09496
131.04049
147.06842
97.05277
87.03203
101.04768
186.07932
163.06333
99.06842

1.3 False discovery rates and target-decoy approach
In proteomics, a database search algorithm is used to obtain confidence metrics such as p-value
and e-value after examining spectra against peptides in a database. The algorithm performs
verification for a single peptide identification using these metrics. These metrics represent the
goodness of fit of an observed spectrum and the corresponding peptide candidate, but most
search engines assign all experimental MS/MS spectra to peptides in a database if they are
within specified mass tolerance. It has previously been observed that only 10-50% of spectrum assignments are correct in MS/MS experiments [43]. This is because not all peptides are
included in the reference database and incorrect peptide candidates sometimes can outscore
correct sequences. For small datasets, it is reasonable to manually examine each PSM to ver-
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ify identification correctness, but in the current large-scale, high-throughput proteomics, this
strategy is not viable. For a large group of identification, rather than examining the correctness of each assignment, the proportion of incorrect identifications is estimated for assignment
verification, which is called false discovery rate (FDR) estimation.

1.3.1 Target-Decoy Search Strategy
Large-scale proteomics requires a method to estimate the proportion of incorrect peptide assignments among correct assignments. Target-decoy search strategy [44] is simple to implement and a standard strategy to estimate FDR in large-scale proteomics. To estimate FDR in
the target-decoy search strategy, decoy peptide sequences that do not exist in nature are created.
The target-decoy search strategy assumes that the original peptide database (target database)
and the decoy database do not overlap so that decoy hits are incorrect assignments. Decoy
sequences, therefore, should be constructed to avoid the common peptide sequences between
the target and the decoy database and to preserve the general composition of the sequences in
the target database.
The other assumption of this strategy is that false positive identifications are equally likely
to come from the target database and the decoy database. Incorrect decoy peptides should
be similar to incorrect but unknown peptides derived from target peptides regarding peptide
length, amino acid composition, peptide mass, and output scores from the search engine. Experimental MS/MS spectra are then searched against the target and decoy database. Since
peptide sequences in the decoy database cannot exist in the sample, any PSMs to the decoy
sequences are incorrect identifications and one can estimate the relative proportion of target
and decoy sequences.

1.3.2 Decoy sequence construction
Several methods for constructing decoy sequences have been developed. Each method has
its advantages and disadvantages, and there is no single best way to create a decoy database.
Reversing the amino acid sequences in the target database is one of the simplest and most com-
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mon ways to create decoy sequences. This method has advantages in that the general features
of the target sequence such as peptide length and amino acid composition are preserved. Also,
this reversal method is so simple to implement that other researchers can create the same decoy
sequences. On the other hand, this method has disadvantages in that decoy sequences by reversal are not random transformations and it is difficult to create decoy peptides corresponding
to the target sequences with palindromic or low complexity.
Shuffling sequences is another method for decoy sequence construction. Since this method
randomly rearranges the target peptide sequence, it is easy to deploy and preserves peptide
length and amino acid composition of the target sequences like the reversal method.
One can also completely randomize the sequences to generate decoy sequences. Randomized sequences should preferably have the same distribution of peptide length and amino acid
composition as those in a target database. For that purpose, the random method first creates a
frequency matrix of amino acids and a histogram of peptide length in the target database, and
then randomly chooses amino acids according to the frequency matrix, and adds these amino
acids until a specified length. The shuffle method and the random method have a drawback in
that they do not preserve redundancies and homologies between peptide sequences, and thus
there can be much more decoy sequences than sequences in the target database. For FDR
estimation, this imbalance and observed decoy bias should be considered.
There are two main types to carry out target-decoy search (Figure 1.9). Separate database
search is performed by searching the target database and the decoy database separately. In the
separate search, two identifications are reported for each spectrum: the target identification
from the best score in the target database and the decoy identification from the best score
in the decoy database. When searching the target and the decoy database separately, there
is no competition between target and decoy sequences for the top-ranked score in a single
search. Some researchers argue that decoy sequences that partially match high-quality MS/MS
spectra are likely to get higher scores than other top-ranked matches in the separate database
search, and thus higher score threshold should be used [44]. Also, separate database search
has difficulty in estimating correct identifications with the low scores because of incorrect
identifications with high scores.
Concatenated database search is performed by combining a database of the target and decoy
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sequences. In the concatenated search, only one match with the best score from either target
or decoy sequences is reported for each spectrum based on the idea that when a given PSM is
correct, the target sequence is expected to produce a higher score than the decoy sequence. On
the other hand, when a PSM is not correct, there is an equal probability of matching a target
sequence and a decoy sequence.

1.3.3 FDR estimation
In the context of the target-decoy search strategy, true positive (TP) means the number of correct assignments above a given score threshold, whereas false positive (FP) means the number
of incorrect assignments above a given score threshold. True negative (TN) represents the
number of incorrect assignments below a given score threshold, whereas false negative (FN)
represents the number of correct assignments below a given score threshold.
Sensitivity refers to the fraction of all correct assignments above a given score threshold,
and using the above notations, it can be written as

Sensitivity =

TP
TP + FN

(1.1)

On the other hand, specificity represents the fraction of all incorrect assignments above a
given score threshold written as

Specificity =

TN
TN + FP

(1.2)

Precision is the fraction of correct assignments above a given score threshold that is calcu-
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lated by

Precision =

TP
TP + FP

(1.3)

FDR is the fraction of incorrect assignments above a given score threshold, which estimates
the ratio of the incorrect PSMs among the accepted PSMs in the target-decoy search strategy,
written as

FDR = 1 − Precision
FP
=
TP + FP

(1.4)
(1.5)

Separate/simple FDR simply computes the ratio of the number of decoy PSMs above the
threshold and the number of target PSMs above the threshold for a given score threshold:

FDR =

Number of decoy PSMs above the threshold (D)
Number of target PSMs above the threshold (T )

(1.6)

where decoy PSMs are reported by searching a decoy peptide database and target PSMs are
reported by searching the original peptide database.
Concatenated database search assumes that there is the same number of false identifications
in target PSMs above a given threshold as the number of decoys above the threshold, and
therefore, the number of false positives is doubling the number of decoy PSMs above the
threshold. The true positive PSMs tend to match the target sequences, while the false positive
PSMs are equally distributed among target and decoy sequences. The number of decoy PSMs
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represents half the number of false positive PSMs.

FDR =

2×D
T +D

(1.7)

Figure 1.9: Schema of separate database search and concatenated database search [45]

Käll et al. [46] proposed a more sophisticated calculation method than simple separate
FDR by incorporating the percentage of incorrect target PSMs (PIT). Separate FDR does not
consider incorrect target PSMs. The target-decoy search strategy assumes not all target PSMs
are correct while all decoy PSMs contribute to incorrect matches, and thus, the set of target
PSMs consists of a mixture of correct and incorrect target PSMs. This bimodal target score
distribution containing correct and incorrect target hits causes an overestimation of FDR. To
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consider this bias, these incorrect target PSMs need to be factored into the calculation of FDR.
To estimate the PIT, which is also commonly known as π, from the observed score distributions,
PIT is calculated by the ratio of the number of false discoveries to the total number of PSMs.
For example, supposing 1000 target PSMs, which contain 200 correct PSMs and 800 incorrect
PSMs, PIT equals 0.8. Then, the FDR of this method is the ratio of the number of decoy
PSMs to the number of target PSM multiplied by PIT, 0.8 in this example. This method needs
estimation of PIT based on the experimental score distributions. Factoring into this correction
weight allows FDR estimation more accurate.

FDR = PIT ×

D
T

(1.8)

Extensive research has been carried out to examine the methods for FDR estimation for
peptide identification, but there have been no common methods to calculate FDR for glycopeptide identification because of the great diversity of glycan structures. In this thesis, we carry
out various approaches for decoy glycan database construction based on target-decoy search
strategy for validation of peptide identification. However, the target-decoy strategy for peptide
identification and that for glycopeptide identification is different in that peptides consists of
a linear sequence of amino acids whereas glycans are composed of monosaccharide in a tree
structure. One of the strategies employed in previous research is generating theoretical target
glycopeptide spectra and adding a random mass to Y-ions of the target spectra, which yield
decoy spectra. We constructed decoy glycan databases by maintaining the tree structure of
the glycans and changing the monosaccharides in the tree. In addition, we employ a mixture
model that facilitates distinguishing between correct and incorrect identifications among the
database search score distribution for a better comparison of different decoy glycan database
construction and examines the appropriateness and effectiveness of the simple FDR estimation
method.

Chapter 2
Methods
2.1 Datasets
In this work, publicly available RAW MS data of mouse brain glycopeptide samples were
retrieved from PRIDE proteomics database [47]. This dataset was analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) using an Orbitrap mass analyzer with
HCD fragmentation. The protein database was obtained from UniProtKB/Swiss-Prot [48].
The following parameters of the database search software were used in our experiment. The
precursor mass tolerance was ±10 p.p.m., the fragment ion mass tolerance for peptide was
±0.2 Da, and the fragment ion mass tolerance for glycan was ± 20 p.p.m. Trypsin was used as

the enzyme for protein digestion. PTMs were specified for glycan search. Carbamidomethylation on cysteine residues (C + 57.02 Da) was set as the fixed modification, in which all cysteine
residues were modified. Oxidation on methionine residues (M + 15.99 Da) was set as the variable modification, some of which were modified. There were 2794 N-glycans in our target
glycan database.

2.2 Notations
There are various kinds of monosaccharides, but in this study, we considered six frequently
observed monosaccharide residue types: Hex, HexNAc, Fuc, Xyl, NeuAc, and NeuGc (Table
2.1). Since glucose, mannose, and galactose have the same formula and mass, they are classi20
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fied into Hex in this work. In the same way, N-Acetylglucosamine and N-Acetylgalactosamine
are categorized as HexHAc.
Table 2.1: Types of monosaccharides
Monosaccharide

Symbol

Galactose
Glucose
Mannose
N-Acetylgalactosamine
N-Acetylglucosamine
Fucose
Xylose
N-Acetylneuraminic acid
N-Glycolylneuraminic acid

Monoisotopic
mass
162.0528
162.0528
162.0528
203.0794
203.0794
146.0579
132.0423
291.0954
307.0903

Generic term
Hex
Hex
Hex
HexNAc
HexNAc
Fuc
Xyl
NeuAc
NeuGc

There were 2794 glycans in our glycan database in which each glycan is represented by
GlycoCT connection table-based format. To construct decoy glycan databases, glycans in GlycoCT format were transformed into glycans represented by the linear notation (Figure 2.1).
GlycoCT

Glycan structure

Linear representation

HexNAc(HexNAc(Hex(Hex)(Hex)))

Figure 2.1: Glycan tree example
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2.3 Decoy glycan construction
To construct a decoy glycan database, we rearranged nodes of a glycan in the target database
while keeping the target glycan structure. In addition, we generated decoy glycan sequences so
that there were no common sequences between the target glycan database and the decoy glycan
database, which conforms to the key assumption of the target-decoy search strategy.

2.3.1 Permutation method
This method permutates all the monosaccharides in a given glycan (Figure 2.2). After carrying
out multiple sets of permutations for each glycan, we selected a decoy glycan sequence that had
a maximum tree edit distance [49] from the corresponding target glycan sequence. The glycan
topology and the composition of monosaccharides in a given target sequence were preserved
for the corresponding decoy glycan in this method. We created decoy glycan databases from
10 sets, 30 sets, and 60 sets of permutation.

Target glycan

Decoy glycan

Figure 2.2: Permutation method

2.3.2 Swap method
The swap method replaces nodes between a pair of monosaccharides, which has the effect of
randomly adding or subtracting a certain amount of mass to the corresponding target glycan.
First, we made three pairs of monosaccharides that have similar residue mass (Table 2.1): Hex
and HexNAc, Fuc and Xyl, and NeuAc and NeuGc. Then, a monosaccharide was swapped
with the other monosaccharide in the pair. For example, if a Hex node is presented at a given
position of the tree structure in a target glycan, the Hex node is changed to a HexNAc node on
the same position of the same tree structure in the corresponding decoy glycan (Figure 2.3). In
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this method, glycan topology is preserved but monosaccharide composition and glycan mass
are different between the target glycan and the corresponding decoy glycan. We created swapbased decoy databases where 50%, 75%, and 100% of monosaccharides in a target glycan were
swapped to generate the corresponding decoy glycan.

Target glycan

Decoy glycan

Figure 2.3: Swap method

2.3.3 Random method
For the random method, we first observed the frequency of each monosaccharide in the whole
target database: HexNAc, 0.380; Hex, 0.409; Fuc, 0.103; Xyl, 0.001; NeuAc, 0.058; and
NeuGc, 0.049. We then randomly chose monosaccharides for each node in the glycan tree in
accordance with the monosaccharide frequency in the target database (Figure 2.4). Similar to
the swap method, monosaccharide composition and glycan mass in the target glycan sequence
were not preserved for the corresponding decoy glycan sequence, although the tree structure
for the decoy glycan was maintained in the random method.

Target glycan

Decoy glycan

Figure 2.4: Random method
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2.4 Software
GlycanFinder is an advanced feature of PEAKS Studio [50], which is a software platform that
performs protein identification and quantification, PTM analysis, and peptide de novo sequencing, that is designed to identify and quantify glycopeptides from LC-MS/MS spectra data. The
software tool provides identification of glycosylation sites and visualization of the N-linked
and O-linked glycan structures, annotation of spectra, and glycan de novo sequencing for a
comprehensive analysis and interpretation of glycopeptides. The software is a preliminary version developed by Bioinformatics Solutions Inc. GlycanFinder has the default built-in glycan
database, but we can incorporate our own decoy glycan database into the software and compare
the results from different decoy glycan databases. Although the new version of this software
has been developed recently, we show the results from the previous version we have been using
in this thesis. For the default decoy method, the latest version of GlycanFinder adds random
mass to the mass of theoretical target spectra to generate the decoy spectra and search experimental spectra against target and decoy spectra.

2.5 FDR estimation
We calculated FDR by the following simple calculation method:

FDR =

Number of decoy PSMs above the threshold (D)
Number of target PSMs above the threshold (T )

(2.1)

From all the glycopeptide-spectrum matches (GPSMs), FDR for each GPSM was calculated using Equation 2.1. In this work, we focused on the analysis of glycan FDR, which was
obtained by glycan target matches and glycan decoy matches, and analyzed the target glycan
matches and decoy glycan matches below 1% glycan FDR.
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2.6 Comparative search engine
We compared the above decoy construction methods using a different search engine for glycopeptide identification: GlycanFinder and pGlyco 2.0 [51]. pGlyco 2.0 is one of the most
common software tools for intact glycopeptide identification, which conducts glycan-level,
peptide-level, and glycopeptide-level false discovery rate evaluation for glycopeptides. pGlyco
2.0 employs its decoy method based on a mass list of glycopeptides and random addition of
mass. GlycanFinder and pGlyco 2.0 used the same parameter setting for the analysis of mouse
brain glycopeptides.

2.7 Mixture model
From the assumption of the target-decoy strategy that the target database and the decoy database
do not have any overlapped entries, all the decoy hits are incorrect matches. On the other hand,
target hits can contain both correct and incorrect matches. Therefore, the distribution of glycan
scores for target matches can be considered as a mixture of a distribution of glycan scores for
correct matches and a distribution of scores for incorrect matches. The objective of the mixture
model approach is to estimate the distribution parameters from the observed data. To better
assess the effectiveness of glycopeptide identification software, we use a statistical model for a
distinction between correct identifications and incorrect identifications among target matches.
We modeled the distribution of glycan score data with a mixture of two component distributions representing correct score distribution for one and incorrect score distribution for the
other by the Bayesian approach.
It is unknown from which mixture component each observed data comes. The mixture of
multiple distributions is a weighted sum of K components formulated by

f (x; θ1 , ..., θk ) =

K
!

πk fk (x; θk )

(2.2)

k=1

where θk represents parameters of each component in the mixture and the mixing weights πk
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meet the conditions

K
!

πk = 1

(2.3)

k=1

and

πk ≥ 0

(2.4)

The distributions can be the same parametric family of distributions such as normal with different distribution parameters or different distributions.

2.7.1 Bayesian approach
In Bayesian statistics, probability reflects a degree of belief in a hypothesis, and the parameter
θ is modeled as a random variable unlike the frequentist approach, where it determines the
parameter θ that represents the true distribution of data. At an initial stage, probability, in
which prior knowledge about parameters from previous experiences is included, is subjective
to some degree. Then, the degree of belief is updated while observing data. Using this method,
we can infer the parameter θ by producing a probability distribution for θ. Point estimate can be
extracted from the distribution. In the Bayesian method, using a probability density function
P(θ), which is called prior distribution of the parameter θ, that shows the degree of belief
about parameter θ and a statistical model P(x|θ), which is called likelihood that represents
the belief about x given θ with an observation of data x1 , x2 , ..., xn , the belief is updated, and
f (θ|x1 , x2 , ..., xn ), which is called posterior distribution, is calculated.

The joint probability mass function for θ and x is defined as
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P(θ, x) = P(x|θ)P(θ)

(2.5)

Using the conditional probability

P(θ|x) =

P(θ, x)
P(x)

(2.6)

and the law of total probability

P(x) =

n
!
i=1

P(xi |θ)P(θ)

(2.7)

Bayes theorem is defined as

P(xi |θ)P(θ)
P(θ|x) = "n
j=1 P(xi |θ)P(θ)

(2.8)

Since the denominator in equation (2.8) does not depend on θ, and it can be considered a
constant, equation (2.8) can be written as

P(θ|x) ∝ P(x|θ)P(θ)

(2.9)

where the symbol ∝ represents proportionality. Bayesian methods carry out the computation
to yield P(θ|x), which represents the updated belief after observing data.
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2.7.2 Mixture model for glycopeptide score distribution
Since we do not have labels of correct assignments and incorrect assignments in the target
distribution, this mixture model is unsupervised learning that extracts useful information from
unlabeled data for the distinction between correct and incorrect identifications. The score distribution of the glycopeptide assignment was modeled by a one-dimensional mixture model,
in which the score data was one-dimensional with a single variable. The distribution consists
of two component distributions f1 (x; θ1 ) and f2 (x; θ2 ) for correct assignment score distribution
and incorrect assignment score distribution, respectively. This two-component mixture model
can be written by

f (x; θ1 , θ2 ) = π1 f1 (x; θ1 ) + π2 f2 (x; θ2 )

(2.10)

where π1 + π2 = 1. The likelihood and log-likelihood of this mixture model are represented by

L(θ1 , θ2 ) =
=

n
#

n
!
i=1

(2.11)

%
π1 f1 (xi ; θ1 ) + π2 f2 (xi ; θ2 )

(2.12)

$
%
log π1 f1 (xi ; θ1 ) + π2 f2 (xi ; θ2 )

(2.13)

i=1

l(θ1 , θ2 ) =

f (xi ; θ1 , θ2 )

i=1
n $
#

where π1 + π2 = 1. To accurately calculate the probability that glycopeptides are correctly
or incorrectly assigned, models of glycan score distributions for correct and incorrect assignment are needed. From the empirical observation, the distribution of correct glycopeptide
assignment was modeled by normal distribution and the probability of correct glycopeptide
identification having database search score S can be calculated by
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p(S |+) =

1
1 S −µ 2
√ e− 2 ( σ )
σ 2π

(2.14)

with mean µ, standard deviation σ, and + that represents correct glycopeptide assignment,
On the other hand, lognormal distribution can closely approximate the observed incorrect glycopeptide identifications because the shape of the distribution was asymmetric and had a long
right tail. The probability of incorrect glycopeptide identification having a database search
score S can be calculated by

p(S |−) =

1
1 logS −µ 2
e− 2 ( σ )
√
σ 2πS

(2.15)

with mean µ, standard deviation σ, and − that represents incorrect glycopeptide assignment.
Using the Bayes theorem, the probability of correct glycopeptide assignment to spectrum i with
database search score S is calculated by

p(+|S i ) =

π1 f1 (S i )
π1 f1 (S i ) + π2 f2 (S i )

(2.16)

where + represents the correct glycopeptide assignment. The log-likelihood of the mixture
distribution of glycopeptide search score is described by

l =
=

n
!
i=1
n
!
i=1

log f (S i )

(2.17)

$
%
log π1 f1 (S i ) + π2 f2 (S i )

(2.18)

30

Chapter 2. Methods

2.7.3 Markov chain Monte Carlo (MCMC)
To distinguish correct and incorrect identifications, we employed Markov chain Monte Carlo
(MCMC) based mixture model. MCMC is a popular method to determine probability density
function parameters by repeatedly generating samples using Markov chain to find best-fitting
values. The MCMC approach on Bayesian models is a fast and flexible method, especially
when there are numerous parameters, that can be applied to a wide range of problems. The
MCMC-based method does not require evaluation of the likelihood functions, which may have
a large number of integrals. As opposed to maximum likelihood parameter estimation using
numerical optimization, the MCMC generates a sample of parameter values from the posterior
distribution of the model parameters. After a multitude of iterations is carried out, the posterior
distribution is yielded from the sample distribution of the parameters.
The Metropolis algorithm [52] is one of the basic sampling methods for MCMC. The
Metropolis algorithm performs random walks with an acceptance/rejection rule to converge
to the desired target distribution. The algorithm starts with an arbitrarily chosen starting point
of the model parameters, θ0 = (θ10 , ..., θm0 ) from starting probability density p0 (θ). For each iteration t = 1, 2, ..., a candidate for the next sample value θ∗ is generated from proposal distribution
at time t, gt (θ∗ |θt−1 ). The proposal distribution can be chosen depending on the current state

θt−1 , according to the Markov chain property. Then, the acceptance ratio to decide whether the
candidate is accepted or rejected is calculated by

r =

p(θ∗ |y)
p(θt−1 |y)

(2.19)

After sampling the random candidate θ∗ , whether the candidate is accepted or rejected is decided.




∗


θ
t
θ =




θt−1

with probability min(r, 1)
otherwise

(2.20)
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The algorithm calculates the ratio r for all (θ, θ∗ ), and samples θ from the proposal distribution
gt (θ∗ |θ) for all θ and t.
The Metropolis-Hastings [53] algorithm is a generalized method of the Metropolis algorithm. For the Metropolis algorithm, the proposal distribution has to be symmetric, which must
meet the condition gt (θa |θb ) = gt (θb |θa ), but this condition is not required for the MetropolisHastings algorithm. Thus, the acceptance ratio is rewritten as

r =

p(θ∗ |y)/gt (θ∗ |θt−1 )
p(θt−1 |y)/gt (θt−1 |θ∗ )

(2.21)

Due to the asymmetric jumping rules, the Metropolis-Hastings can perform random walks
more efficiently than the basic Metropolis algorithm. This algorithm Converges to the desired
target distribution in the same manner as the Metropolis algorithm does.
Using the MCMC algorithm, we differentiate correct and incorrect glycopeptide assignments from a mixture of two component distributions. Three chains were generated so that
the algorithm had different starting values and evaluate the convergence of MCMC. The first
1000 samples obtained during the adaptive phase were discarded, in which a Markov chain
is not formed. The number of iterations to reach convergence and achieve correctness in the
sampling phase was set to 3000. To control larger jumps in the chain and keep sample values
to be close to the previous samples, the MCMC algorithm kept every 5 sampled values and
discarded other samples. After separating the two distributions, we compare the shape of the
decoy distribution, which is incorrect score distribution based on the key assumption of the
target-decoy search strategy, and the shape of the target incorrect distribution, which is separated from the whole target assignment score distribution.
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2.7.4 Fitting decoy glycan score distribution
We fitted a probability distribution to data from decoy glycan scores by using maximum likelihood estimation. Let data x and the probability of observing data P(x|θ). Since x is known and
the parameter θ is unknown, the value of P(x|θ) is a function of θ, which is called the likelihood
of the data x and is denoted as L(θ; x). Let x = (x1 , ..., xn ) be a sample independently observed
from a distribution, then

L(θ; x) =

n
#

P(x1 |θ)

(2.22)

θ̂ = arg max L(θ; x)

(2.23)

i=1

and the estimate of the parameter is

θ

The lognormal distribution is used to model continuous random variables greater than or equal
to zero. Another characteristic of the lognormal distribution is the distribution is skewed to
the right. By observing the shape of the distribution of the decoy glycan score, we assumed
the lognormal distribution can be better fitted to the data since the lognormal distribution has a
heavier right tail and lighter left tail compared to the other skewed distribution such as gamma
distribution. From the density function for the lognormal distribution

f (x|µ, σ2 ) =

1
1 logx−µ 2
e− 2 ( σ )
√
σ 2πx

(2.24)

where µ ∈ (−∞, +∞) and σ > 0. And the maximum likelihood estimators for µ and σ2 are
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µ̂ =

σ̂2

=

"n

logxi
n

i=1

"n

i=1 (logxi

n

− µ)2

(2.25)

(2.26)

Chapter 3
Results
3.1 Glycan distance comparison for different databases
We first compared the difference between each target and decoy glycan pair because we assumed that if a target glycan and the corresponding decoy glycan are too similar, especially if
the fragment ions of B-ions and Y-ions are too similar, the software tool tends to assign decoy
glycans to a spectrum. Since glycans have a tree structure, in which each monosaccharide can
be treated as a node and each glycosidic bond can be treated as an edge, we calculated the
difference metrics between a target glycan and the corresponding decoy glycan on the basis of
tree edit distance.
There are three types of tree edit operations: insert operation inserts a node, delete operation
deletes a node, and change operation relabels one node to another. Our decoy construction
methods changed monosaccharides while maintaining the tree topologies, the distance can be
calculated by checking each monosaccharide at a certain position in a tree. For example, if the
root node in a target glycan tree is HexNAc and the same position of the node (i.e, the root
node) in the corresponding decoy glycan tree is Hex, we count one to calculate the distance.
Take Figure 3.1 as an example, the distance between target and decoy glycan is 4 and the ratio
of different monosaccharides in a decoy glycan is 0.8.
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Target glycan

Decoy glycan

Figure 3.1: Permutation method

The average tree distance and the ratio of different monosaccharides in a decoy glycan tree for
each decoy glycan construction method are shown in Table 3.1. The more sets of permutations
were carried out, the more tree distance they had among the decoy construction by permutation
methods. The swap methods had the ratio of different monosaccharides according to the swapping percentage. A random decoy database had enough distance between targets and decoys.

Table 3.1: Glycan distance comparison
Decoy construction

Average tree distance

Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

13.20
13.96
14.32
8.23
12.35
15.97
10.77

Ratio of different
monosaccharide
0.82
0.87
0.89
0.52
0.78
1.00
0.67

3.2 FDR estimation for different databases
We then calculated glycan FDR for each decoy glycan construction method using the assignment of glycans to all the spectra. From the largest glycan score to the smallest glycan score,
we applied Equation 2.1 to all the GPSMs. After the glycan FDR calculation, we observed the
number of GPSM at 1%, 2%, and 5%, and the threshold glycan scores for each FDR criteria
(Table 3.2 to 3.4).
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Also, we plotted the FDR curve to observe the relationships between a given FDR and

the number of GPSM (Figure 3.2). As shown in the figure, permutation 10, permutation 30,
and permutation 60 decoy databases had similar curves, although permutation 10 database had
fewer number of matches between FDR of 2% and 4%. Permutation 30 and permutation 60
decoy databases had almost the same number of GPSM below the FDR of 2%, permutation
60 decoy database had more number of GPSM above FDR of 2%. Swap 50 % method had
by far the fewest number of matches at 1% and 2% glycan FDR, while swap 75 % and swap
100 % methods had a much larger number of matches at any FDR threshold, for example,
3264 matches for swap 75 % method and 4672 matches for swap 100 % method at 1% FDR
compared to 674 matches for permutation 60 method. Figure 3.3 to Figure 3.9 show target
glycan score distribution and decoy glycan score distribution for each decoy database method,
and Table 3.5 describes the number of target and decoy matches for each method. If you
look at this information, Swap 50%, Swap 75%, and Swap 100% methods had significantly
fewer decoy matches than the other methods, thus they had much larger GPSM. Therefore we
cannot say that this database method is a reliable method for FDR estimation. We focused on
permutation 10 sets, 30 sets, 60 sets, and random methods in the following analysis.

3.2. FDR estimation for different databases
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Table 3.2: Decoy method comparison at 1% glycan FDR
Decoy construction
Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

Number of GPSM
for 1% glycan FDR
453
522
674
65
3264
4672
1072

Threshold
glycan score
6.79
6.64
6.29
8.81
0.65
0.14
5.25

Table 3.3: Decoy method comparison at 2% glycan FDR
Decoy construction
Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

Number of GPSM
for 2% glycan FDR
877
1692
1884
76
4667
5172
1768

Threshold
glycan score
5.77
3.61
3.00
8.56
0.15
0.11
3.00

Table 3.4: Decoy method comparison at 5% glycan FDR
Decoy construction
Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

Number of GPSM
for 5% glycan FDR
2673
2834
2967
5050
6070
6491
2651

Threshold
glycan score
1.40
1.17
0.99
0.12
0.08
0.07
1.46
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Figure 3.2: Number of GPSM at given glycan FDR

Table 3.5: Number of target/decoy matches for 100% glycan FDR
Decoy construction
Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

Target matches Decoy matches
4525
1449
4625
1281
4640
1244
5172
338
5273
196
5288
140
4642
1436

3.2. FDR estimation for different databases

Figure 3.3: Glycan score distribution of permutaion 10 database

Figure 3.4: Glycan score distribution of permutaion 30 database
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Figure 3.5: Glycan score distribution of permutaion 60 database

Figure 3.6: Glycan score distribution of swap 50% database

3.2. FDR estimation for different databases

Figure 3.7: Glycan score distribution of swap 75% database

Figure 3.8: Glycan score distribution of swap 100% database
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Figure 3.9: Glycan score distribution of random database

3.3 Mixture model-based comparison between incorrect target distribution and decoy distribution
The key assumption of the target-decoy search strategy is that false positive identifications are
equally likely to come from the target database and the decoy database. To be consistent with
this assumption, we first decomposed the target matches into target correct matches and target
incorrect matches, which were normal distribution and lognormal distribution, respectively. In
addition, we fitted the decoy glycan score histogram to lognormal distribution to compare it
with the target incorrect match distribution.
Figure 3.10, 3.12, 3.14, and 3.16 show the histograms of target matches and estimated components of incorrect target score distributions for each decoy database method. Figure 3.11,
3.13, 3.15, and 3.17 show the histograms of decoy matches and fitted decoy score distributions
for each decoy database method. In order to precisely compare the shape of target incorrect
distribution and decoy distribution, we plotted cumulative density for each distribution in Figure 3.18 to 3.21. If the target cumulative distribution curve and decoy cumulative distribution
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curve are completely overlapped, we can assume that the two distributions are identical and
have the same parameters. On the other hand, if the two curves are plotted further from each
other, the shapes of these distributions are not so similar, which means the decoy database
method is not consistent with the assumption of the target-decoy search strategy.

At a first glance, permutation 10, permutation 30, and permutation 60 methods had less gap
between the two distribution curves, whereas the random method had a wider gap between the
curves, which means the random method did not have similar target incorrect distribution and
decoy distribution. More closely looking at Figure 3.18 to 3.21, we compared permutation 10,
permutation 30, and permutation 60 methods in detail, especially the cumulative distribution
function at a threshold glycan score of 1% FDR. The threshold score for 1% glycan FDR score
for the permutation 10 method was 6.79. The cumulative distribution function of 6.79 in target incorrect distribution was 0.982 and the cumulative distribution function of 6.79 in decoy
distribution was 0.990. The threshold score for 1% glycan FDR score for the permutation 30
method was 6.64. The cumulative distribution function of 6.64 in target incorrect distribution
was 0.983 and the cumulative distribution function of 6.64 in decoy distribution was 0.991. The
threshold score for 1% glycan FDR score for the permutation 60 method was 6.29. The cumulative distribution function of 6.29 in target incorrect distribution was 0.981 and the cumulative
distribution function of 6.29 in decoy distribution was 0.991.

From this analysis, the gap between the cumulative distribution function at a threshold
score of 1% FDR for target incorrect distribution and decoy distribution observed by the permutation 60 method was larger and the gaps observed by permutation 10 and permutation 30
were smaller compared to each other. Taking account of the assumption in the target-decoy
strategy that there is an equal probability of incorrect matches from the target database and the
decoy database, the permutation 10 method and the permutation 30 method are more suitable
decoy databases with regard to the similarity between target incorrect distribution and decoy
distribution at their threshold score for 1% FDR.
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Figure 3.10: Estimated target incorrect glycan distribution of 10 sets of permutation database

Figure 3.11: Fitting glycan score distribution of 10 sets of permutation database
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Figure 3.12: Estimated target incorrect glycan distribution of 30 sets of permutation database

Figure 3.13: Fitting glycan score distribution of 30 sets of permutation database
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Figure 3.14: Estimated target incorrect glycan distribution of 60 sets of permutation database

Figure 3.15: Fitting glycan score distribution of 60 sets of permutation database
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Figure 3.16: Estimated target incorrect glycan distribution of random database

Figure 3.17: Fitting glycan score distribution of random database
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Figure 3.18: Cumulative density of incorrect target distribution and decoy distribution for permutation 10 database

Figure 3.19: Cumulative density of incorrect target distribution and decoy distribution for permutation 30 database
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Figure 3.20: Cumulative density of incorrect target distribution and decoy distribution for permutation 60 database

Figure 3.21: Cumulative density of incorrect target distribution and decoy distribution for random database
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3.4 Overlapped identifications between GlycanFinder and pGlyco
To evaluate the performance of each decoy construction method, we counted overlapped glycopeptide identifications by using another glycopeptide sequencing software. We used pGlyco
2.0 as a benchmark software because it is currently one of the most widely used software
tools. GlycanFinder employs its default decoy glycan method, which adds random mass to the
theoretical target glycan mass list to generate decoy spectra, and the software searches experimental spectra against target and decoy glycan spectra. The new version of GlycanFinder has
been developed as of now, but we compare the results obtained from the previous version of
GlycanFinder in this thesis.
Table 3.6 summarizes the overlapped identifications between GlycanFinder and pGlyco 2.0
for 1% glycan FDR. The number of overlapped identification for swap 75 % and swap 100 %
were larger than other methods. However, considering the ratio of the number of overlapped
identifications between GlycanFinder and pGlyco 2.0 to the number of identifications in GlycanFinder, the ratios for swap methods were smaller than that for permutation methods. Thus,
a certain portion of the GlycanFinder identifications by swap 75% and swap 100% method
seems to be not so reliable, although these decoy methods achieved a larger number of identifications for 1% FDR.

3.4. Overlapped identifications between GlycanFinder and pGlyco
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Table 3.6: Number of overlapped identifications between GlycanFinder and pGlyco 2.0
Decoy construction
Default
Permutation 10 sets
Permutation 30 sets
Permutation 60 sets
Swap 50%
Swap 75%
Swap 100%
Random

Number of
identifications
in GlycanFinder
349
453
522
674
65
3264
4672
1072

Overlapped
identifications
with pGlyco 2.0
74
86
96
119
8
264
269
151

Chapter 4
Conclusion and discussion

In this study, we constructed various kinds of decoy glycan databases on the basis of the targetdecoy search strategy: the permutation method, the swap method, and the random method. To
evaluate the effectiveness of each glycan construction method, we compared these databases
from the viewpoint of the tree edit distance between the decoy glycan sequences and the corresponding target glycans, the number of GPSM at a given FDR threshold, and the distribution
of glycan target scores and decoy scores for 100% glycan FDR. Also, we observed the number
of overlapped glycopeptide identifications between GlycanFinder and a benchmark glycopeptide identification software pGlyco 2.0. Furthermore, we estimated a distinction between the
correct assignments and the incorrect assignments among the target glycan score distribution
using the MCMC-based mixture model and compared the shape of the target incorrect distributions and the decoy glycan score distributions for each decoy construction method following
the key assumption of the target-decoy strategy.
From the experimental results, we concluded that the decoy glycan database generated
by the permutation method is a more reasonable method than the swap method and the random method for FDR estimation of glycopeptide identification based on the observation of the
number of GPSM and the ratio of the number of GlycanFinder identifications to the number
of overlapped identifications with pGlyco 2.0. With regard to the comparison of the shape
of the target incorrect distributions and the decoy glycan score distributions, the permutation
approaches achieved a more similar shape of the two distributions, which can satisfy the as52
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sumption of equal likeliness of false positives in the target database and the decoy database in
the target-decoy search strategy. Among the permutation methods, the gap of the cumulative
distribution function of a threshold glycan score of 1% FDR between the target incorrect distribution and the decoy distribution was larger in the permutation 60 method, whereas the gap
was smaller in the permutation 10 and the permutation 30 method. However, the difference in
the metrics among these methods is rather small and the difference may have come from the
difference in the threshold score of 1% FDR.
There are, however, some possible limitations in this study. In this work, we used the
mouse brain glycopeptide dataset for FDR estimation of glycopeptide identification yielded by
GlycanFinder, and compared these results against those produced by the benchmark software
pGlyco 2.0. More various kinds of datasets can be used to validate the performance of decoy
glycan construction approaches, and another benchmark glycopeptide identification software
apart from pGlyco 2.0 for a better comparison of the number of their identifications in future
work.
Another limitation of this study concerns the mixture model to distinguish correct assignments and incorrect assignments in the target score distribution. We employed the unsupervised
normal-lognormal mixture model and compared the distribution curves. A further study could
employ a semisupervised mixture model using the information from decoy matches, which
represents incorrect assignments. Also, another family of distributions apart from normal and
lognormal distribution could be considered for modeling the two-component mixture.
Furthermore, we constructed decoy glycan databases by assigning monosaccharides to each
tree node while maintaining the glycan tree structure in this study to have a similar monosaccharide composition as the glycans in the target database, specifically for the permutation
method and the random method. In future investigations, it might be possible to construct
a decoy glycan database by changing the glycan tree structure from the corresponding target
tree structure.
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